Isabella Attinger-Toller

Author

Also Known As

Isabella Attinger-Toller, Isabella Attinger-toller

Publications

184

Citations

H-Index

Concepts

All Affiliations

Isabella Attinger-Toller is an author at Janssen (Switzerland) specializing in immunology, immunotherapy, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	129
2	Immunology	3	3	129
3	Allergy	1	1	90
4	Cell Biology	1	1	25
5	Pathology	1	1	90

Isabella Attinger-Toller

Publications

171

Citations

H-Index

Page 1

	Year	Citations
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases Michela Silacci, Wibke Lembke, Richard Woods, mAbs Immune RegulationImmunologyPathologyImmunotherapyPsoriatic Arthritis	2015	90
A Bispecific HER2-Targeting FynomAb with Superior Antitumor Activity and Novel Mode of Action Simon Brack, Isabella Attinger-Toller, Babette Schade, Molecular Cancer Therapeutics	2014	42
Bispecific CD3/HER2 Targeting FynomAb Induces Redirected T Cell-Mediated Cytolysis with High Potency and Enhanced Tumor Selectivity Ulrich Wuellner, Kristina Klupsch, Fabian Buller, Antibodies High Her2 DensityRadiation OncologyCancer ImmunosurveillanceEnhanced Tumor SelectivityHigh Potency	2015	25
COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia Kristina Klupsch, Vanessa Baeriswyl, Roland W. Scholz, Leukemia Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2018	14

Page 1